Skip to content
RX3341RX3341RX3341

Drawing based on the label description. No photo yet.

“BAXDELA Tablets: Modified capsule shaped tablets in beige to mottled beige color with RX3341 debossed on one side containing 450 mg delafloxacin (equivalent to 649 mg delafloxacin meglumine)”

RX3341 pill

Pill with imprint RX3341 is brown, capsule, 21 mm and has been identified as Delafloxacin Meglumine 450 mg. It is used for bacterial infections and skin infections. It is supplied by Melinta Therapeutics, LLC.

Delafloxacin Meglumine 450 mg

Imprint
RX3341
Strength
450 mg
Used for
Bacterial infections and skin infections
Color
Brown
Shape
Capsule / oblong
Size
21 mm
Score
No score line
Form
Tablet
Manufacturer
Melinta Therapeutics, LLC
Drug class
Antibiotic (fluoroquinolone)
NDC
70842-101, 70842-101-03, 70842-101-02, 70842-101-01, 70842-101-05

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Delafloxacin Meglumine pills and guides

What is Delafloxacin Meglumine used for?

Delafloxacin Meglumine is used for bacterial infections and skin infections.

Medicine type
Antibiotic (fluoroquinolone)
Official uses from the US prescribing label

Acute Bacterial Skin and Skin Structure Infections

BAXDELA is indicated in adults for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by the following susceptible microorganisms: Staphylococcus aureus (including methicillin-resistant [MRSA] and methicillin-susceptible [MSSA] isolates), Staphylococcus haemolyticus, Staphylococcus lugdunensis, Streptococcus agalactiae, Streptococcus anginosus Group (including Streptococcus anginosus, Streptococcus intermedius, and Streptococcus constellatus), Streptococcus pyogenes, Enterococcus faecalis, Escherichia coli, Enterobacter cloacae, Klebsiella pneumoniae, and Pseudomonas aeruginosa.

Community-Acquired Bacterial Pneumonia

BAXDELA is indicated in adults for the treatment of community-acquired bacterial pneumonia (CABP) caused by the following susceptible microorganisms: Streptococcus pneumoniae, Staphylococcus aureus (methicillin-susceptible [MSSA] isolates only), Klebsiella pneumoniae, Escherichia coli, Pseudomonas aeruginosa, Haemophilus influenzae, Haemophilus parainfluenzae, Chlamydia pneumoniae, Legionella pneumophila, and Mycoplasma pneumoniae.

Usage

To reduce the development of drug-resistant bacteria and maintain the effectiveness of BAXDELA and other antibacterial drugs, BAXDELA should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

From the FDA-approved label on DailyMed (published Aug 11, 2025).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows RX3341 and the other side has no imprint.
  • It is brown, capsule, 21 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Baxdela.

Ingredients

Active: Delafloxacin Meglumine

Inactive: Microcrystalline Cellulose, Povidone K30, Crospovidone (35 .mu.m), Sodium Bicarbonate, Sodium Phosphate, Monobasic, Monohydrate, Anhydrous Citric Acid, Magnesium Stearate, Water

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Delafloxacin Meglumine pills